Antiviral treatment of patients with recurrent hepatitis c after liver transplantation with pegylated interferon

Digestive Diseases and Sciences

Volumn 55, Issue 7, 2010, Pages 2063-2069

  Schmidt, Sven C ^a   Bahra, Marcus ^a   Bayraktar, Sandra ^a   Berg, Thomas ^a   Schmeding, Maximilian ^a   Pratschke, Johann ^a   Neuhaus, Peter ^a   Neumann, Ulf ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antiviral treatment; Liver transplantation; Recurrent hepatitis C

Indexed keywords

CYCLOSPORIN A; PEGINTERFERON ALPHA2B; RIBAVIRIN; TACROLIMUS;

ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL TRIAL; DRUG WITHDRAWAL; ESOPHAGUS VARICES; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MYALGIA; PANCYTOPENIA; PNEUMONIA; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME; VIREMIA; VIRUS LOAD;

ADULT; AGED; ANTIVIRAL AGENTS; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ODDS RATIO; POLYETHYLENE GLYCOLS; PROBABILITY; RECURRENCE; RETROSPECTIVE STUDIES; RIBAVIRIN; RISK ASSESSMENT; ROC CURVE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VIRAL LOAD;

EID: 77954427473     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0982-2     Document Type: Article

References (35)

1. RM Ghobrial DG Farmer A Baquerizo S Colquhoun HR Rosen H Yersiz JF Markmann KE Drazan C Holt D Imagawa LI Goldstein P Martin RW Busuttil 1999 Orthotopic liver transplantation for hepatitis C: Outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience Ann Surg 229 824 831 10.1097/00000658-199906000-00009 10363896 (Pubitemid 30191732)
2. RM Ghobrial J Gornbein R Steadman N Danino JF Markmann C Holt D Anselmo F Amersi P Chen DG Farmer S Han F Derazo S Saab LI Goldstein SV McDiarmid RW Busuttil 2002 Pretransplant model to predict posttransplant survival in liver transplant patients Ann Surg 236 315 322 10.1097/00000658-200209000-00008 12192318 (Pubitemid 34971341)
3. EJ Gane NV Naoumov KP Qian MU Mondelli G Maertens BC Portmann JY Lau R Williams 1996 A longitudinal analysis of hepatitis C virus replication following liver transplantation Gastroenterology 110 167 177 10.1053/gast.1996.v110. pm8536853 8536853 (Pubitemid 26021616)
4. EJ Gane BC Portmann NV Naoumov HM Smith JA Underhill PT Donaldson G Maertens R Williams 1996 Long-term outcome of hepatitis C infection after liver transplantation [see comments] N Engl J Med 334 815 820 10.1056/ NEJM199603283341302 8596547 (Pubitemid 26099603)
5. PA Sheiner LK Schluger S Emre SN Thung JY Lau SR Guy ME Schwartz CM Miller 1997 Retransplantation for recurrent hepatitis C Liver Transplant Surg 3 130 136 10.1002/lt.500030205
6. GV Papatheodoridis S Davies AP Dhillon R Teixeira J Goulis B Davidson K Rolles G Dusheiko AK Burroughs 2001 The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis Transplantation 72 412 418 10.1097/00007890-200108150-00009 11502968
7. M Berenguer 2002 Natural history of recurrent hepatitis C Liver Transplant 8 10 Suppl 1 S14 S18 10.1053/jlts.2002.35781 (Pubitemid 35154038)
8. LM Forman JD Lewis JA Berlin HI Feldman MR Lucey 2002 The association between hepatitis C infection and survival after orthotopic liver transplantation Gastroenterology 122 889 896 10.1053/gast.2002.32418 11910340
9. EJ Gane SK Lo SM Riordan BC Portmann JY Lau NV Naoumov R Williams 1998 A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation Hepatology 27 1403 1407 10.1002/hep.510270530 9581698 (Pubitemid 28227870)
10. MS Cattral AW Hemming IR Wanless H Al Ashgar M Krajden L Lilly PD Greig GA Levy 1999 Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantation Transplantation 67 1277 1280 10.1097/00007890- 199905150-00014 10342322 (Pubitemid 29239481)
11. D Samuel T Bizollon C Feray B Roche SN Ahmed C Lemonnier M Cohard M Reynes M Chevallier C Ducerf J Baulieux M Geffner JK Albrecht H Bismuth C Trepo 2003 Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomized study Gastroenterology 124 642 650 10.1053/gast.2003.50095 12612903 (Pubitemid 36268483)
12. S Zeuzem SV Feinman J Rasenack EJ Heathcote MY Lai E Gane J O'Grady J Reichen M Diago A Lin J Hoffman MJ Brunda 2000 Peginterferon alfa-2a in patients with chronic hepatitis C New Engl J Med 343 1666 1672 10.1056/ NEJM200012073432301 11106715
13. U Neumann G Puhl M Bahra T Berg JM Langrehr R Neuhaus P Neuhaus 2006 Treatment of patients with recurrent hepatitis C after liver transplantation with peginterferon alfa-2B plus ribavirin Transplantation 82 43 47 10.1097/01.tp.0000225827.18034.be 16861940 (Pubitemid 44296976)
14. S Beckebaum VR Cicinnati X Zhang M Malago O Dirsch Y Erim A Frilling CE Broelsch G Gerken 2004 Combination therapy with peginterferon alpha-2B and ribavirin in liver transplant recipients with recurrent HCV infection: Preliminary results of an open prospective study Transplant Proc 36 1489 1491 10.1016/j.transproceed.2004.05.017 15251366 (Pubitemid 38903011)
15. M Biselli P Andreone A Gramenzi S Lorenzini E Loggi F Bonvicini C Cursaro M Bernardi 2006 Pegylated interferon plus ribavirin for recurrent hepatitis C infection after liver transplantation in naïve and non-responder patients on a stable immunosuppressive regimen Dig Liver Dis 38 27 32 10.1016/j.dld.2005.08.009 16311084 (Pubitemid 44356137)
16. M Castedal M Felldin L Bäckman M Olausson S Friman 2005 Preemptive therapy with pegylated interferon alpha-2b and ribavirin after liver transplantation for hepatitis C cirrhosis Transplant Proc 37 3313 3314 10.1016/j.transproceed.2005.09.018 16298583 (Pubitemid 41659875)
17. N Chalasani C Manzarbeitia P Ferenci W Vogel RJ Fontana M Voigt C Riely P Martin L Teperman J Jiao JC Lopez-Talavera Pegasys Transplant Study Group 2005 Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials Hepatology 41 289 298 10.1002/hep.20560 15660392 (Pubitemid 40165372)
18. J Dumortier JY Scoazec P Chevallier O Boillot 2004 Treatment of recurrent hepatitis C after liver transplantation: A pilot study of peginterferon alfa-2b and ribavirin combination J Hepatol 40 669 674 10.1016/j.jhep.2003.12.015 15030984 (Pubitemid 38367790)
19. M Fontana D Ciuffreda D Moradpour M Pascual 2007 Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation Transplantation 83 525 526 10.1097/01.tp.0000251974.97869.6f 17318091 (Pubitemid 46667862)
20. M Heydtmann D Freshwater T Dudley V Lai S Palmer S Hübscher D Mutimer 2006 Pegylated interferon alpha-2b for patients with HCV recurrence and graft fibrosis following liver transplantation Am J Transplant 6 825 833 10.1111/j.1600-6143.2006.01255.x 16539640 (Pubitemid 43345021)
21. JM Moreno Planas E Rubio Gonzalez E Boullosa Graña A Garrido Botella C Barrios Peinado JL Lucena Poza M Jiménez Garrido V Sanchez Turrion V Cuervas-Mons Martinez 2005 Peginterferon and ribavirin in patients with HCV cirrhosis after liver transplantation Transplant Proc 37 2207 2208 10.1016/j.transproceed.2005.03.124 15964380 (Pubitemid 40956413)
22. S Mukherjee J Rogge L Weaver DF Schafer 2003 Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation Transplant Proc 35 3042 3044 10.1016/j.transproceed.2003.10.083 14697974 (Pubitemid 38102126)
23. VJ Desmet M Gerber JH Hoofnagle M Manns PJ Scheuer 1994 Classification of chronic hepatitis: Diagnosis, grading and staging Hepatology 19 1513 1520 10.1002/hep.1840190629 8188183
24. DV Gopal JM Rabkin BS Berk CL Corless S Chou A Olyaei SL Orloff HR Rosen 2001 Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin Liver Transplant 7 181 190 10.1053/jlts.2001.22447 (Pubitemid 32243812)
25. J Ahmad SF Dodson AJ Demetris JJ Fung AO Shakil 2001 Recurrent hepatitis C after liver transplantation: A nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin Liver Transplant 7 863 869 10.1053/jlts.2001.27869 (Pubitemid 33040460)
26. AB Alberti LS Belli A Airoldi L de Carlis G Rondinara E Minola M Vangeli A Cernuschi M D'Amico D Forti G Pinzello 2001 Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: A pragmatic study Liver Transplant 7 870 876 10.1053/jlts.2001.27871 (Pubitemid 33040461)
27. T Walter J Dumortier O Guillaud V Hervieu P Paliard JY Scoazec O Boillot 2007 Rejection under alpha interferon therapy in liver transplant recipients Am J Transplant 7 177 184 10.1111/j.1600-6143.2006.01590.x 17227566 (Pubitemid 44952871)
28. BJ Veldt JJ Poterucha KD Watt RH Wiesner JE Hay WK Kremers CB Rosen JK Heimbach MR Charlton 2008 Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection Am J Transplant 8 2426 2433 10.1111/j.1600-6143.2008.02362.x 18727694
29. M Berenguer 2008 Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin J Hepatol 49 274 287 10.1016/j.jhep.2008.05.002 18571272
30. M Schmeding A Dankof V Krenn MG Krukemeyer M Koch A Spinelli JM Langrehr UP Neumann P Neuhaus 2006 C4d in acute rejection after liver transplantation-a valuable tool in differential diagnosis to hepatitis C recurrence Am J Transplant 6 523 530 10.1111/j.1600-6143.2005.01180.x 16468961 (Pubitemid 43382138)
31. MP Manns JG McHutchison SC Gordon VK Rustgi M Shiffman R Reindollar ZD Goodman K Koury M Ling JK Albrecht 2001 Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial Lancet 358 958 965 10.1016/S0140-6736(01)06102- 5 11583749 (Pubitemid 32913521)
32. RJ Firpi H Zhu G Morelli MF Abdelmalek C Soldevila-Pico VI Machicao R Cabrera AI Reed C Liu DR Nelson 2006 Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation Liver Transplant 12 51 57 10.1002/lt.20532
33. Y Sugawara J Kaneko M Makuuchi 2006 Cyclosporin a for treatment of hepatitis C virus after liver transplantation Transplantation 82 579 580 10.1097/01.tp.0000229397.81425.51 16926607 (Pubitemid 44290269)
34. E Oton R Barcena JM Moreno-Planas V Cuervas-Mons A Moreno-Zamora C Barrios S Garcia-Garzon A Moreno E Boullosa-Graña EE Rubio-Gonzalez M Garcia-Gonzalez C Blesa ML Mateos 2006 Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose PEG-interferon and ribavirin Am J Transplant 6 2348 2355 10.1111/j.1600-6143.2006.01470.x 16869810 (Pubitemid 44359420)
35. M Bahra UP Neumann D Jacob JM Langrehr T Berg R Neuhaus P Neuhaus 2007 Fibrosis progression in hepatitis C positive liver recipients after sustained virologic response to antiviral combination therapy (interferon-ribavirin therapy) Transplantation 83 351 353 10.1097/01.tp.0000250575.92788.aa 17297412